CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

Clinical Trial2016 Oct 11;68(15):1622-1632.

JOURNAL:J Am Coll Cardiol. Article Link

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial

Henriques JP, Hoebers LP, EXPLORE Trial Investigators. Keywords: STEMI; CTO; non-infarct-related artery; left ventricular ejection fraction; left ventricular end diastolic volume; cardiac magnetic resonance

FULL TEXT PDF